Transcription factor-based transdifferentiation of human embryonic to trophoblast stem cells.


Journal

Development (Cambridge, England)
ISSN: 1477-9129
Titre abrégé: Development
Pays: England
ID NLM: 8701744

Informations de publication

Date de publication:
01 Sep 2024
Historique:
received: 26 02 2024
accepted: 05 08 2024
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 9 9 2024
Statut: ppublish

Résumé

During the first week of development, human embryos form a blastocyst composed of an inner cell mass and trophectoderm (TE) cells, the latter of which are progenitors of placental trophoblast. Here, we investigated the expression of transcripts in the human TE from early to late blastocyst stages. We identified enrichment of the transcription factors GATA2, GATA3, TFAP2C and KLF5 and characterised their protein expression dynamics across TE development. By inducible overexpression and mRNA transfection, we determined that these factors, together with MYC, are sufficient to establish induced trophoblast stem cells (iTSCs) from primed human embryonic stem cells. These iTSCs self-renew and recapitulate morphological characteristics, gene expression profiles, and directed differentiation potential, similar to existing human TSCs. Systematic omission of each, or combinations of factors, revealed the crucial importance of GATA2 and GATA3 for iTSC transdifferentiation. Altogether, these findings provide insights into the transcription factor network that may be operational in the human TE and broaden the methods for establishing cellular models of early human placental progenitor cells, which may be useful in the future to model placental-associated diseases.

Identifiants

pubmed: 39250534
pii: 361974
doi: 10.1242/dev.202778
pii:
doi:

Substances chimiques

Transcription Factors 0
GATA3 Transcription Factor 0
GATA2 Transcription Factor 0
Transcription Factor AP-2 0
GATA2 protein, human 0
GATA3 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 221856/Z/20/Z
Pays : United Kingdom
Organisme : Wellcome Human Developmental Biology Resource
ID : 215116/Z/18/Z
Organisme : Francis Crick Institute
Organisme : National Medical Research Council
ID : CSAINV17may001
Organisme : King's College London
Organisme : UK Research and Innovation
ID : MR/W006693/1

Informations de copyright

© 2024. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Auteurs

Paula A Balestrini (PA)

Centre for Gene Therapy and Regenerative Medicine, King's College London, London SE1 9RT, UK.

Ahmed Abdelbaki (A)

Human Embryo and Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
The Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.
Department of Zoology, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.

Afshan McCarthy (A)

Human Embryo and Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Liani Devito (L)

Human Embryo and Stem Cell Unit, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Claire E Senner (CE)

The Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.

Alice E Chen (AE)

Trestle Biotherapeutics, Centre for Novel Therapeutics, 9310 Athena Circle, La Jolla, CA 92037, USA.

Prabhakaran Munusamy (P)

KK Women's and Children's Hospital, Division of Obstetrics and Gynecology, 100 Bukit Timah Road, Singapore229899, Singapore.

Paul Blakeley (P)

Human Embryo and Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Department of Surgery, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China.

Kay Elder (K)

Bourn Hall Clinic, Bourn, Cambridge CB23 2TN, UK.

Phil Snell (P)

Bourn Hall Clinic, Bourn, Cambridge CB23 2TN, UK.

Leila Christie (L)

Bourn Hall Clinic, Bourn, Cambridge CB23 2TN, UK.

Paul Serhal (P)

The Centre for Reproductive & Genetic Health, 230-232 Great Portland Street, London W1W 5QS, UK.

Rabi A Odia (RA)

The Centre for Reproductive & Genetic Health, 230-232 Great Portland Street, London W1W 5QS, UK.

Mahesh Sangrithi (M)

Centre for Gene Therapy and Regenerative Medicine, King's College London, London SE1 9RT, UK.
KK Women's and Children's Hospital, Division of Obstetrics and Gynecology, 100 Bukit Timah Road, Singapore229899, Singapore.
Duke-NUS Graduate Medical School, Cancer Stem Cell Biology/OBGYN ACP, 8 College Road, Singapore 169857, Singapore.

Kathy K Niakan (KK)

Human Embryo and Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
The Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.
Wellcome Trust - Medical Research Council Stem Cell Institute, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.
Epigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.

Norah M E Fogarty (NME)

Centre for Gene Therapy and Regenerative Medicine, King's College London, London SE1 9RT, UK.
Human Embryo and Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH